Mallinckrodt plc MNKKQ Stock
Mallinckrodt plc Price Chart
Mallinckrodt plc MNKKQ Financial and Trading Overview
- Mallinckrodt plc Price Chart
- Mallinckrodt plc MNKKQ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Mallinckrodt plc
- Q&A For Mallinckrodt plc Stock
|Mallinckrodt plc stock price||0.02 USD|
|Previous Close||0.02 USD|
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.02 - 0.02 USD|
|52 Week Range||0.001 - 0.36 USD|
|Avg. Volume||344.47K USD|
|Market Cap||1.69M USD|
|Beta (5Y Monthly)||2.818627|
|PE Ratio (TTM)||N/A|
|EPS (TTM)||0 USD|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MNKKQ Valuation Measures
|Enterprise Value||82.67M USD|
|PEG Ratio (5 yr expected)||N/A|
Mallinckrodt plc Stock Price History
|Beta (5Y Monthly)||2.818627|
|S&P500 52-Week Change||N/A|
|52 Week High||0.36 USD|
|52 Week Low||0.001 USD|
|50-Day Moving Average||0.06 USD|
|200-Day Moving Average||0.12 USD|
MNKKQ Share Statistics
|Avg. Volume (3 month)||344.47K USD|
|Avg. Daily Volume (10-Days)||0 USD|
|% Held by Insiders||11.18%|
|% Held by Institutions||0.40%|
|Short % of Float||50.07%|
|Short % of Shares Outstanding||49.32%|
Dividends & Splits
|Trailing Annual Dividend Rate||N/A|
|Trailing Annual Dividend Yield||N/A|
|5 Year Average Dividend Yield||N/A|
|Last Split Factor|
|Fiscal Year Ends||December 31, 2021|
|Most Recent Quarter (mrq)||December 31, 2021|
|Next Fiscal Year End||December 31, 2023|
|Operating Margin (ttm)||5.21%|
|Return on Assets (ttm)||0.77%|
|Return on Equity (ttm)||-108.58%|
|Revenue (ttm)||2.21B USD|
|Revenue Per Share (ttm)||26.08 USD|
|Quarterly Revenue Growth (yoy)||-12.50%|
|Gross Profit (ttm)||891.7M USD|
|Net Income Avi to Common (ttm)||-723500032 USD|
|Diluted EPS (ttm)||-7.869|
|Quarterly Earnings Growth (yoy)||N/A|
|Total Cash (mrq)||1.34B USD|
|Total Cash Per Share (mrq)||15.87 USD|
|Total Debt (mrq)||1.42B USD|
|Total Debt/Equity (mrq)||453.1 USD|
|Current Ratio (mrq)||1.189|
|Book Value Per Share (mrq)||6.06|
Cash Flow Statement
|Operating Cash Flow (ttm)||455.4M USD|
|Levered Free Cash Flow (ttm)||855.04M USD|
Profile of Mallinckrodt plc
|Address||College Business & Technology Park|
|Phone||353 1 696 0000|
|Industry||Drug Manufacturers—Specialty & Generic|
|Full Time Employees||2778|
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes; and gastrointestinal products. It offers Acthar Gel, a repository corticotropin injection for rheumatoid arthritis, infantile spasms, systemic lupus erythematosus, multiple sclerosis, systemic dermatomyositis, symptomatic sarcoidosis, severe acute and chronic allergic, and inflammatory diseases; INOmax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Therakos photopheresis, an immunotherapy treatment platform; Amitiza for constipation; and StrataGraft for the treatment of adults with deep partial-thickness burns. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; and SLN 501 is a ribonucleic acid silencing therap. In addition, it provides specialty generic drugs and active pharmaceutical ingredients. The company markets its branded products to physicians, respiratory therapists, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc to develop and commercialize ribonucleic acid interference drug targets. The company was founded in 1867 and is based in Dublin, Ireland. On October 12, 2020, Mallinckrodt plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Q&A For Mallinckrodt plc Stock
What is a current MNKKQ stock price?
Mallinckrodt plc MNKKQ stock price today per share is 0.02 USD.
How to purchase Mallinckrodt plc stock?
You can buy MNKKQ shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mallinckrodt plc?
The stock symbol or ticker of Mallinckrodt plc is MNKKQ.
Which industry does the Mallinckrodt plc company belong to?
The Mallinckrodt plc industry is Drug Manufacturers—Specialty & Generic.
How many shares does Mallinckrodt plc have in circulation?
The max supply of Mallinckrodt plc shares is 0.
What is Mallinckrodt plc Price to Earnings Ratio (PE Ratio)?
Mallinckrodt plc PE Ratio is 0.00000000 now.
What was Mallinckrodt plc earnings per share over the trailing 12 months (TTM)?
Mallinckrodt plc EPS is 0 USD over the trailing 12 months.
Which sector does the Mallinckrodt plc company belong to?
The Mallinckrodt plc sector is Healthcare.